Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-25-182307
Filing Date
2025-08-18
Accepted
2025-08-18 08:59:03
Documents
7

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d82697dsc14d9.htm SC 14D9 460354
2 EX-99.(E)(12) d82697dex99e12.htm EX-99.(E)(12) 50266
3 EX-99.(E)(13) d82697dex99e13.htm EX-99.(E)(13) 36592
4 EX-99.(E)(14) d82697dex99e14.htm EX-99.(E)(14) 52264
5 EX-99.(E)(15) d82697dex99e15.htm EX-99.(E)(15) 36507
6 GRAPHIC g82697g01r04.jpg GRAPHIC 34130
7 GRAPHIC g82697g02r07.jpg GRAPHIC 54439
  Complete submission text file 0001193125-25-182307.txt   759912
Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Subject) CIK: 0001888012 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-93640 | Film No.: 251226393
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)